NCT00037765Active, not recruiting
Gene Modifiers of Cystic Fibrosis Lung Disease
Source: ClinicalTrials.gov · Last updated 3 Nov 2026
Brief summary (registry, in English)
The purpose of this study is to examine genetic modifiers of the severity of cystic fibrosis lung disease.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 600 (estimated)
- First submitted
- 20 May 2002
- Start date
- Sept 2001
- Primary completion date
- Jul 2028
- Lead sponsor
- University of North Carolina, Chapel Hill
- Diseases
- Cystic fibrosis
- NCT number
- NCT00037765
What you commit to
- Study type: Observational
- Planned participants: 600
- From Sept 2001 to the primary completion date, Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Only those subjects who are not able to consent to this protocol
Who the study is looking for
- Diagnosed with CF
Age in the registry: - to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Marsico Lung Institute Coordinator of this site? Confirm its status | Chapel Hill | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.